Philadelphia officials this week unveiled the city's first mobile narcotic treatment program, an RV-style van operated by Merakey that rolls directly into neighborhoods to connect people struggling with opioid use disorder to medication and long-term treatment. City leaders introduced the vehicle at the Kensington Wellness Support Center, an area long at the center of the city's overdose crisis.
According to NBC10 Philadelphia, Mayor Cherelle Parker highlighted the city's efforts to combat opioid use disorder as she touted the new mobile unit's early results. Parker said that, per the city's figures, 567 people have already received treatment through the program and 207 have been stabilized and reconnected with their families. “Ultimately, we are going to save more lives in the city of Philadelphia,” Parker said, according to the outlet's report.
What the Van Actually Offers
Merakey, the nonprofit operating the vehicle, provides medication-assisted treatment for people experiencing serious withdrawal symptoms from narcotics, with the mobile unit focused on methadone. The organization's broader addiction-recovery offerings include outpatient treatment, counseling, recovery support and community-based services for adults seeking help with substance use. Suboxone and Vivitrol are managed at Merakey's physical outpatient locations. Merakey also runs a separate outreach effort, the Parkside Recovery Mobile Intake and Assessment Team, which connects people experiencing substance-use or co-occurring behavioral-health challenges to care.
The federal government identifies methadone as one of three medications approved to treat opioid use disorder, alongside buprenorphine and naltrexone, according to the U.S. Food and Drug Administration. The Substance Abuse and Mental Health Services Administration similarly lists methadone among the medications used in opioid use disorder treatment.
Years in the Making
Philadelphia had floated the idea of mobile methadone clinics years earlier. In a January 2023 report, The Philadelphia Inquirer described city plans to fund vans staffed with medical workers that would travel into neighborhoods and offer what officials called a low-barrier form of opioid addiction treatment. At the time, the outlet noted Philadelphia was one of the first U.S. cities in more than a decade to enter talks with the federal government over such a program.
That funding was tied to Pennsylvania's opioid settlement, from which Philadelphia expected to receive roughly $200 million over 18 years, having collected about $20 million by early 2023, per the Inquirer's reporting. The push came against the backdrop of a historic overdose crisis: Philadelphia recorded 1,276 unintentional overdose deaths in 2021, the highest annual rate in the city's history, according to NBC10 Philadelphia.
The Case for Mobile Treatment
The Recovery Research Institute reports that 11% of people with past-year opioid use disorder received medication treatment.
The city's launch of Merakey's van marks a new chapter in that broader strategy, bringing treatment access directly to communities rather than asking people to find their way to a clinic. With hundreds already reported treated in the program's early stretch, city officials are framing the mobile unit as a tangible step toward addressing an overdose crisis that has reshaped Philadelphia neighborhoods for years.
